
GSK vs PRQR
$GSK vs $PRQR head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs PRQR: trend, levels and the market
One year to 2026-11-20, against the S&P 500 (+3.2%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Neither kept up with the market over the past year: GSK +1.6% and PRQR -52.7%, against the S&P 500 at +3.2%.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
GSK vs PRQR: the quick read
- ·GSK is the larger company by market cap ($95.73B vs $147M).
- ·GSK has been more active on our scanner (77 vs 75 alerts in 30 days).
- ·PRQR has the smaller float (125.7M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·They trade in different worlds by share price: PRQR is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·Both stay busy on our scanner, 77 and 75 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are not really peers by size: GSK is more than 652x the market cap of PRQR, so the same dollar of news moves PRQR far harder.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·GSK pays a dividend and PRQR does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Watching GSK or PRQR? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and PRQR on TheDesperateTrader.
- Is GSK or PRQR the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($95.73B vs $147M). GSK has been more active on our scanner (77 vs 75 alerts in 30 days). PRQR has the smaller float (125.7M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and PRQR?
- The differences that matter: GSK is roughly 652x the size of the other by market cap ($95.73B vs $147M); they trade at very different share prices ($47.96 vs $1.03); GSK sits at 14% of its 52-week range against 2% for PRQR; only GSK pays a dividend; our scanner flagged GSK 77 times in the last 30 days against 75 for PRQR. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and PRQR is more active right now?
- Right now GSK is at about 0.6x its normal volume and PRQR is at about 1.1x, so PRQR is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is GSK or PRQR in the stronger trend?
- GSK is below its 50-day average of $49.31 and below its 200-day average of $52.25; PRQR is below its 50-day average of $1.49 and below its 200-day average of $1.66. GSK leads 4 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or PRQR? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.